Jaguar Health Status
The company raised $6.95 million in its second public offering on the Nasdaq stock exchange under the ticker symbol of JAGX on October 4, 2018. A total of 11,575,001 shares were sold at $0.6 per share. After the offering, there was a total of 26,423,329 outstanding shares (excluding the over-allotment option) priced at $0.6 per share, valuing the company at $15.85 million. The underwriters were granted an option to purchase up to an additional 2,250,000 shares from the company to cover over-allotments, if any.
Add a review